arrow1 Comment
  1. Stephen Williams
    Aug 19 - 1:10 am

    I am happy that both Pfizer (with their commitment to CTI and Novartis (most recently with their $20 million commitment to create a center of excellence at Univ. of Pennsylvania) have realized that academic-industry partnerships are needed in this environment. However, as an academic researcher who has been involved with contract agreements with pharmaceutical firms, it is important, as with dating, that each partner understand the needs and goals of their counterpart in order for the greatest benefit to arise from such collaborations. Just as industry has aspirations for new applications academia has goals resulting in new innovative basic research. Thru mutual understanding of each other’s goals more expedient and transformative discoveries can be realized.

Mobile Theme